CS
NBP

Candriam SCA’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Candriam SCA’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.79M Hold
1,132,563
– – 0.01% 466
2025
Q4 		$4.51M Hold
1,132,563
– – 0.02% 387
2025
Q3 		$4.28M Hold
1,132,563
– – 0.02% 392
2025
Q2 		$2.74M Buy
+1,132,563
New +$1.54M 0.02% 448
2020
Q3 		– Sell
-32,624
Closed -$977K – 816
2020
Q2 		$977K Buy
+32,624
New +$675K 0.01% 601

Other funds holding NBP

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
ACM
AIHC Capital Management Central $120M AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return

Candriam SCA's NBP Position: Q1 2026 in Review

Candriam SCA held its NovaBridge Biosciences American Depositary Shares (NBP) position steady in Q1 2026 at 1,132,563 shares worth $2.79M. The position accounts for 0.01% of the portfolio, ranked #466.

Candriam SCA first reported a position in NBP in Q2 2020 and has held it in 5 quarters since. The position peaked at $4.51M in Q4 2025. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.

  • Candriam SCA held 1,132,563 shares of NovaBridge Biosciences American Depositary Shares worth $2.79M as of Q1 2026.
  • Candriam SCA left its NovaBridge Biosciences American Depositary Shares share count unchanged in Q1 2026.
  • NovaBridge Biosciences American Depositary Shares made up 0.01% of Candriam SCA's portfolio in Q1 2026, its #466 holding.
  • Candriam SCA first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2020 and has held it in 5 quarters since.
  • Candriam SCA's NovaBridge Biosciences American Depositary Shares position peaked at $4.51M in Q4 2025.
  • 48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.

Based on Candriam SCA's 13F filing for Q1 2026, filed 30 Apr 2026.